SNDL Inc. Website

SNDL Inc.

NasdaqCM-SNDL

Company Overview

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Cannabis Operations and Retail Operations segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use markets; and private sale of recreational cannabis through corporate owned and franchised retail cannabis stores. The company also produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.

  • Name

    SNDL Inc.

  • CEO

    Zachary Ryan George

  • Website

    www.sndl.com

  • Sector

    Pharmaceuticals

  • Year Founded

    2006

Company Statistics

Profile

  • Market Cap

    —

  • EV

    —

  • Shares Out

    —

  • Revenue

    —

  • Employees

    —

Margins

  • Gross

    —

  • EBITDA

    —

  • Operating

    —

  • Pre-Tax

    —

  • Net

    —

  • FCF

    —

Returns (5Yr Avg)

  • ROA

    —

  • ROTA

    —

  • ROE

    —

  • ROCE

    —

  • ROIC

    —

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    —

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    —

  • Net Debt

    —

  • Debt/Equity

    —

  • EBIT/Interest

    —

Growth (CAGR)

  • Rev 3Yr

    —

  • Rev 5Yr

    —

  • Rev 10Yr

    —

  • Dil EPS 3Yr

    —

  • Dil EPS 5Yr

    —

  • Dil EPS 10Yr

    —

  • Rev Fwd 2Yr

    —

  • EBITDA Fwd 2Yr

    —

  • EPS Fwd 2Yr

    —

  • EPS LT Growth Est

    —

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

What's happening

Nov 12, 2025 - Dec 12, 2025

SNDL Inc Faces Significant Challenges Amid Market Uncertainty

  • SNDL Inc. announced a renewed share repurchase program allowing for up to C$100 million in buybacks, yet this did not significantly boost investor confidence.
  • Speculative discussions regarding artificial intelligence's impact on the cannabis industry failed to translate into positive stock performance for SNDL.
  • The company continues to struggle with operational issues, reflected in its negative net margin and revenue falling short of consensus estimates.

Over the past month, SNDL Inc. experienced a decline of 7.6%, which is notably worse than the S&P 500's modest gain of 0.7%. This underperformance highlights ongoing challenges within the cannabis sector, where mixed analyst sentiments and financial hurdles persist. While one firm initiated coverage with a "buy" rating, others downgraded their assessments, resulting in an average rating of "hold." The company's financial metrics reveal significant issues such as a negative net margin alongside revenues that did not meet consensus expectations.

A key event during this period was SNDL's announcement on November 24 regarding its renewed share repurchase program approved by the Canadian Securities Exchange. This program permits up to C$100 million in buybacks over one year starting from November 21, 2025. Under this approval, management can repurchase approximately 24.5 million shares or about 10% of its public float based on market conditions at their discretion. Although this news led to a brief uptick in stock price by nearly 9.3% on that day, it ultimately could not counteract overall bearish trends.

Compounding these challenges were speculative discussions surrounding artificial intelligence’s potential impact on the cannabis industry noted just days prior; however, these speculations did not lead to immediate positive action for SNDL’s stock price either before or after they surfaced during pre-market hours on November 25th.

The cumulative effect of these events has made investors cautious amid uncertain market conditions influenced by broader economic indicators affecting sentiment across various sectors including health care—wherein SNDL underperformed against Health Care (XLV) sector benchmarks by -9.5%. Overall investor confidence appears shaken due to fluctuating expectations around regulatory developments and corporate strategies within the cannabis landscape.

SNDL Inc underperformed relative to both general market indices and specific sector benchmarks; it lagged behind the Health Care (XLV) sector by -9.5%.

NasdaqCM:SNDL